| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.0052 | 1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |